We are live on ! Find out more
SWM

SeaCrest Wealth Management Portfolio holdings

AUM $903M
1-Year Est. Return 47.26%
This Fund
S&P 500
This Quarter Est. Return
+7.12%
1 Year Est. Return
+47.26%
3 Year Est. Return
+141.83%
5 Year Est. Return
+177.26%
10 Year Est. Return
AUM
$879M
AUM Growth
+$60.8M
Cap. Flow
+$17.1M
Cap. Flow %
1.95%
Top 10 Hldgs %
32.91%
Holding
643
New
40
Increased
302
Reduced
225
Closed
30

Top Sells

Rank Stock Value
1
IBM icon
IBM
IBM
+$1.47M
2
LRCX icon
Lam Research
LRCX
+$1.45M
3
SFST icon
Southern First Bancshares
SFST
+$1.25M
4
CVS icon
CVS Health
CVS
+$1.24M
5
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$1.13M

Sector Composition

Rank Sector Weight
1 Technology 27.72%
2 Communication Services 8.84%
3 Financials 7.63%
4 Healthcare 6.74%
5 Consumer Discretionary 5.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FLG
601
Flagstar Bank National Association
FLG
$5.87B
$88.3K 0.01%
9,140
-97
-1% -$938
BGS icon
602
B&G Foods
BGS
$303M
$86.2K 0.01%
10,670
-4,500
-30% -$44.4K
CHW
603
Calamos Global Dynamic Income Fund
CHW
$516M
$74.6K 0.01%
10,869
-5,041
-32% -$33.4K
AQN icon
604
Algonquin Power & Utilities
AQN
$4.59B
$65.7K 0.01%
+11,213
New +$69.5K
SAVE
605
DELISTED
Spirit Airlines, Inc.
SAVE
$63K 0.01%
+17,204
New +$66.6K
CLOV icon
606
Clover Health Investments
CLOV
$2.23B
$62.6K 0.01%
50,900
TEF
607
DELISTED
Telefonica
TEF
$47K 0.01%
11,169
-15
-0.1% -$66
DC icon
608
Dakota Gold
DC
$617M
$33.4K ﹤0.01%
13,111
-122
-0.9% -$325
BTAI icon
609
BioXcel Therapeutics
BTAI
$24.8M
$20.2K ﹤0.01%
984
-94
-9% -$3.15K
FBIO icon
610
Fortress Biotech
FBIO
$111M
$18.8K ﹤0.01%
+11,000
New +$19.9K
TLRY icon
611
Tilray
TLRY
$543M
$18.7K ﹤0.01%
1,125
+30
+3% +$576
CUE icon
612
Cue Biopharma
CUE
$118M
$16.1K ﹤0.01%
433
AIM
613
AIM ImmunoTech
AIM
$6.65M
$13.1K ﹤0.01%
351
ADSK icon
614
Autodesk
ADSK
$51.8B
-1,073
Closed -$279K
ALB icon
615
Albemarle
ALB
$13.4B
-2,078
Closed -$274K
APP icon
616
Applovin
APP
$134B
-5,590
Closed -$387K
BCC icon
617
Boise Cascade
BCC
$2.73B
-1,660
Closed -$255K
BF.B icon
618
Brown-Forman Class B
BF.B
$13.5B
-4,530
Closed -$234K
CIM
619
Chimera Investment
CIM
$1.06B
-9,445
Closed -$131K
CRSP icon
620
CRISPR Therapeutics
CRSP
$4.69B
-3,364
Closed -$229K
CSGP icon
621
CoStar Group
CSGP
$12.2B
-2,131
Closed -$206K
CVNA icon
622
Carvana
CVNA
$47.5B
-27,530
Closed -$484K
CXW icon
623
CoreCivic
CXW
$2.94B
-14,947
Closed -$233K
DEO icon
624
Diageo
DEO
$49.6B
-2,790
Closed -$415K
EEM icon
625
iShares MSCI Emerging Markets ETF
EEM
$27.5B
-6,588
Closed -$271K

Similar funds

SeaCrest Wealth Management's Q2 2024 Portfolio in Review

As of Q2 2024, SeaCrest Wealth Management held 643 positions worth $879M, up 7.4% from $818M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

SeaCrest Wealth Management's Q2 2024 filing shows 40 new, 302 increased, 225 reduced and 30 closed positions. Its largest new stake was GE Vernova: 9,468 shares worth $1.62M. The largest sale was IBM, an estimated $1.47M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Communication Services and Financials.

  • SeaCrest Wealth Management's largest Q2 2024 buy was GE Vernova: 9,468 shares worth $1.62M.
  • SeaCrest Wealth Management added most to NVIDIA in Q2 2024, an estimated $2.36M increase.
  • SeaCrest Wealth Management's biggest Q2 2024 reduction was IBM, cutting an estimated $1.47M.
  • SeaCrest Wealth Management fully exited Carvana in Q2 2024, selling an estimated $484K.
  • SeaCrest Wealth Management's ten largest holdings make up 33% of its $879M portfolio in Q2 2024.
  • SeaCrest Wealth Management opened 40 new positions and closed 30 in Q2 2024.
  • SeaCrest Wealth Management's portfolio value rose 7.4% quarter-over-quarter to $879M.

Based on SeaCrest Wealth Management's 13F filing for Q2 2024, filed 22 Jul 2024.